Ocular Therapeutix (OCUL) Current Leases (2019 - 2026)

Ocular Therapeutix's Current Leases history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Current Leases rose 47.03% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 47.03% YoY), while the FY2025 annual figure was $2.8 million, up 45.73% from the prior year.
• Current Leases was $3.2 million for Q1 2026 at Ocular Therapeutix, up from $2.8 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.2 million in Q1 2026 to a low of $1.5 million in Q1 2024.
• Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $1.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Current Leases declined 15.18% in 2024, then soared 60.86% in 2025.
• A 5-year view of Current Leases shows it stood at $1.6 million in 2022, then slipped by 0.81% to $1.6 million in 2023, then rose by 21.88% to $1.9 million in 2024, then soared by 45.73% to $2.8 million in 2025, then advanced by 12.53% to $3.2 million in 2026.
• The last three Current Leases figures came in at $3.2 million (Q1 2026), $2.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.